BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18493866)

  • 21. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
    Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
    J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
    Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
    Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation in astrocytomas: deposition of C4d and patient outcome.
    Mäkelä K; Helén P; Haapasalo H; Paavonen T
    BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
    Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
    Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
    Zhao M; Xu H; Liang F; He J; Zhang J
    Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
    Wang M; Tang J; Liu S; Yoshida D; Teramoto A
    J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.
    Reddy PS; Umesh S; Thota B; Tandon A; Pandey P; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
    Cancer Biol Ther; 2008 May; 7(5):663-8. PubMed ID: 18728403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas.
    Zhang L; Kundu S; Feenstra T; Li X; Jin C; Laaniste L; El Hassan TE; Ohlin KE; Yu D; Olofsson T; Olsson AK; Pontén F; Magnusson PU; Nilsson KF; Essand M; Smits A; Dieterich LC; Dimberg A
    Sci Signal; 2015 Dec; 8(406):ra125. PubMed ID: 26645582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
    Jang FF; Wei W; De WM
    J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
    Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
    Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors.
    Gupta K; Radotra BD; Banerjee AK; Nijhawan R
    Anal Quant Cytol Histol; 2004 Aug; 26(4):223-9. PubMed ID: 15457675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
    Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.